Skip to content
Neuronet
Neuronet - The support action for EU research on neurodegeneration
  • ABOUT
        • Objectives
        • Glossary
        • Work Packages
        • Partners
        • Executive Committee
        • Task Forces
        • Working Groups
        • Scientific Coordination Board
  • EVENTS
        • 2021: Virtual event
        • 2020: Virtual Event
        • 2019: The Hague
        • Event Calendar
  • NEWS
        • Latest news
        • Neuronet newsletters
        • Neuronet in the Media
  • PROJECTS
        • Ongoing Projects
        • Completed Projects
        • Project Overview
        • Project Timescales
  • RESOURCES
        • Asset Map
        • Project Tools
        • Regulatory & HTA Decision Tool
        • Neuronet Tools
        • Neuronet Deliverables
        • Neuronet Presentations
        • Publications
        • Useful resources for young researchers
  • KNOWLEDGE BASE

IMPRiND

Spotlight on early-career investigators: an interview with Benjamin Falcon

25th August 202121st November 2019
An interview with early career investigator Benjamin Falcon Group Leader Neuronet 800 x 532

Dr Benjamin Falcon is a postdoctoral scientist at the UK Medical Research Council Laboratory of

Neuronet Scientific Coordination Board meeting brings together project leaders in The Hague

14th January 202223rd October 2019
Neuronet Scientific Coordination Board meeting The Hague Alzheimer Europe

On 23 October (The Hague, Netherlands), Neuronet (Efficiently Networking European Neurodegeneration Research) convened the second

Spotlight on early-career investigators: an interview with Benjamin Falcon

4th February 202017th September 2019
An interview with early career investigator Benjamin Falcon Group Leader Neuronet 800 x 532

Dr Benjamin Falcon is a postdoctoral scientist at the UK Medical Research Council Laboratory of

Neuronet Scientific Coordination Board meeting brings together project leaders

3rd December 20217th July 2019
Scientific Coordination Board, Carlos Diaz, Hugh Marston, George Tofaris, Mercè Boada, Pieter Jelle Visser, Darrel Pemberton, Craig Ritchie, Andreas Ebneth, Malcolm Macleod, Margot Bakker

Neuronet’s high-level, overarching Scientific Coordination Board is formed by 15 leaders of Innovative Medicines Initiative projects focussed on neurodegeneration.

IMPRiND scientists work out structure of tau filaments in dementia associated with head injuries

10th January 202220th March 2019
The image shows a cross-section of the type-I CTE filament, with the two (identical, symmetry-related) protofilaments shown in light and darker blue and the unidentified density shown in (dark) red.A cross section of the type-I CTE filament. Credit: MRC-LMB

Scientists have unravelled the structure of the abnormal tau filaments associated with chronic traumatic encephalopathy.

Two IMPRiND researchers win Brain Prize!

4th February 20206th March 2018
Brain Prize Winners Michel Goedert Bart de Strooper IMPRiND Neuronet

The Brain Prize 2018 is awarded to Bart De Strooper, Michel Goedert, Christian Haass and

Post navigation
Newer posts
← Previous Page1 Page2

LATEST NEWS

  • Neuronet publishes Frontiers in Neurology article, analysing the structure, assets and collaborative networks in the IMI neurodegeneration portfolio

    9th November 2022
    The Innovative Medicines Initiative (IMI) was launched in 2008, with an initial budget of €8bn.Read More
  • Spotlight on Early-Career researchers a Neuronet interview with Ilja Saris

    5th September 2022
    In this Neuronet spotlight on early-career researcher interview, we speak with Ilja Saris who worksRead More
  • Spotlight on Communication experts: A Neuronet Blog with Cindy Birck

    29th August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More
  • Webinar series: Mobilise-D presents its four patient cohorts

    25th August 2022
    Mobilise-D starts the autumn webinar series presenting the needs, technologies, protocols and user perspectives forRead More
  • Spotlight on Communication experts: A Neuronet Blog with Yoanna de Geus

    23rd August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More

Neuronet

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 821513. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

Any information on this website solely reflects the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

 

 

Innovative Medicines InitiativeEU Flag logoEuropean Federation of Pharmaceutical Industries and Associations logoParksinson's UK logo

Disclaimer
About IMI
Legal notice
Privacy policy

@ 2019 – IMI-NEURONET

© 2025 - IMI-NEURONET
We use cookies to offer you a better browsing experience and to analyze site traffic. Read about how we use cookies and how you can control them in our Cookie Policy. If you continue to use this site, you consent to our use of cookies. AcceptCookie policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT